Progyny Inc

Healthcare · Healthcare Plans

25.20$ +1.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Progyny Inc (PGNY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 716 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PGNY
Line item	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	–	–	41	58	63	73	150	180	178	202	254	295	312	337	358	416	463	510	543	650	682	727	757	794	699	660	607	730	761	795	742	698	716
Current Assets	4.7	–	–	25	41	46	53	132	162	160	185	190	228	238	254	259	309	356	402	434	527	561	611	640	682	582	546	473	568	594	622	552	502	513
Cash	-4.7	–	–	0.1	0.4	0.3	7.7	80	92	49	54	70	30	49	92	91	39	55	73	120	155	171	158	97	115	95	91	162	109	133	134	112	133	153
Cash & Short-Term Investments	4.7	–	–	0.1	0.4	0.3	7.7	80	92	91	105	109	107	94	114	119	106	122	141	189	208	282	336	371	372	262	236	228	256	305	345	310	226	237
Receivables	–	–	–	23	39	44	44	47	66	65	78	76	117	141	135	135	198	230	258	240	313	265	269	242	297	294	281	235	300	272	253	220	264	257
Inventory	–	–	–	–	–	0.0	0.0	–	0.0	0.0	0.0	–	–	–	0.0	0.0	–	0.0	0.0	–	–	0.0	–	0.0	0.0	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	–	–	–	–	0.8	0.7	1.0	3.1	3.7	3.6	3.5	3.4	3.6	12	13	13	5.8	6.3	14	8.4	8.9	9.5	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	16	16	16	20	20	20	20	20	20
Intangible Assets	–	–	–	3.9	3.5	3.1	2.7	2.4	2.0	1.8	1.5	1.2	1.0	0.8	0.7	0.6	0.5	0.3	0.2	0.1	–	–	–	–	–	1.5	1.4	1.3	6.8	6.6	6.4	6.2	6.0	5.7
Total Liabilities	–	–	–	30	43	41	58	36	59	58	75	87	110	108	113	106	136	152	164	166	225	212	211	203	223	242	225	185	263	246	235	226	259	263
Current Liabilities	–	–	–	30	43	41	58	36	59	58	74	78	101	99	104	99	129	145	157	160	207	194	193	186	206	225	208	169	237	220	210	202	236	240
Short-Term Debt	–	–	–	0.3	6.6	3.1	–	–	–	–	–	1.2	3.1	–	–	1.2	–	–	–	1.2	1.2	1.5	1.8	2.1	2.5	2.8	2.9	2.9	2.9	3.1	3.4	3.7	4.0	4.5
Accounts Payable	–	–	–	16	19	24	23	19	39	32	42	44	57	55	55	61	85	93	104	109	146	130	132	125	130	152	130	95	146	141	123	124	158	152
Shareholders' Equity	11	–	–	11	14	23	15	114	121	120	127	167	185	205	224	252	280	311	347	377	424	469	515	553	572	456	435	422	467	515	560	516	439	453
Retained Earnings	–	–	–	-105	-102	-101	-109	-113	-109	-111	-106	-68	-53	-34	-18	-2.4	2.5	11	25	28	46	61	77	90	107	123	134	144	159	176	190	203	227	255
Shares Outstanding	5.7	5.7	82	71	82	82	82	64	100	85	99	99	100	100	100	100	100	100	100	100	100	101	101	101	101	98	94	95	89	90	90	89	85	82

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings